Overview

Tier 1 funded ($25,000) start-up focused on improving patient retention in clinical trials using mobile technology and machine learning to continuously and intelligently monitor medication dosing events in real-time. ------------------------------------------------------------------------------------------------------------------------- The lengthy screening, enrollment, and randomization process means retaining every patient through the entire study matters. As scheduled visits are only periodic, continuous patient engagement is essential, however, current methods are time intensive and inefficient. The good news: technology can help. Through real-time adherence data, TRIALLA automatically notifies sites of patients at high-risk for drop out so investigators can take early action.